Medical Optimization & Management of Pregnancies with Overt Type 2 Diabetes (MOMPOD)

D
David Haas, MD

Primary Investigator

Administratively Closed
18 years - 45 years
Female
Phase N/A
1 Location

Brief description of study

The purpose of this research study is to determine the safety and effectiveness of adding metformin to insulin to treat type 2 diabetes in pregnant women.

Detailed description of study

This study will compare the effectiveness of insulin + placebo vs. insulin + metformin.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: pregnant,type 2 diabetes,1804212161
  • Age: 18 years - 45 years
  • Gender: Female
Updated on 22 May 2025. Study ID: OBGYN-NIH-MOMPOD001V17, 1804212161

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the Study Team